Kemadrin Trademark Details

Kemadrin was registered on Tuesday, October 20, 1953 and is currently owned by Monarch Pharmaceuticals, Inc. under the registration number 581264 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, April 1, 2016, according to the United State Patent & Trademark Office
Word Mark Kemadrin
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Monarch Pharmaceuticals, Inc. of Bristol, TN

View all trademarks for Monarch Pharmaceuticals, Inc.
Other Trademarks for Monarch Pharmaceuticals, Inc.

Previous Owners

Burroughs Wellcome Co. of Research Triangle Park, NC

View all trademarks for Burroughs Wellcome Co.
Other Trademarks for Burroughs Wellcome Co.

Burroughs Wellcome & Co. (U.S.A.) Inc. of Tuckahoe, NY

View all trademarks for Burroughs Wellcome & Co. (U.S.A.) Inc.
Other Trademarks for Burroughs Wellcome & Co. (U.S.A.) Inc.
Serial Number 71634030
Registration Number 581264
Status Date Friday, April 1, 2016
Filing Date Friday, April 1, 2016
Registration Date Tuesday, October 20, 1953
Attorney Seana Smith

Correspondent

Seana Smith
Pfizer Inc.
150 East 42nd Street
New York NY 10017

Case File Statements

Goods & Services Medicinal Preparation Intended for the Treatment of Parkinsonism

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, April 1, 2016
First Use Anywhere Thursday, July 10, 1952
First Use In Commerce Thursday, July 10, 1952
Primary Code 018

You must be signed in to print.

Once signed in, look for the PDF button.